Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
21 NC counties are under alert, including Northampton County.
Program
On WRAL at 6: WRAL Investigates why a school took nearly two years to report alleged abuse to law enforcement and parents.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by NKGen Biotech
NKGen Biotech to Present New Positive SNK01 Clinical Trial Biomarker Data at the 2024 Alzheimer’s Association International Conference
July 18, 2024
From
NKGen Biotech
Via
GlobeNewswire
Tickers
NKGN
NKGen Biotech Appoints Dr. Marco Gottardis to its Board of Directors
July 15, 2024
From
NKGen Biotech
Via
GlobeNewswire
Tickers
JNJ
NKGN
NKGen Biotech Presents Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy for Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024
June 12, 2024
From
NKGen Biotech
Via
GlobeNewswire
Tickers
NKGN
NKGen Biotech to Present at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting
May 02, 2023
From
NKGen Biotech
Via
GlobeNewswire
NKGen Biotech, Inc. to Become Publicly Traded Company via Business Combination with Graf Acquisition Corp. IV
April 14, 2023
From
NKGen Biotech
Via
GlobeNewswire
Tickers
GFOR
NKGen Biotech Announces Formation of Scientific Advisory Board to Drive its Pipeline Strategy for Natural Killer Cell Therapies Targeting Neurodegenerative Diseases
March 08, 2023
From
NKGen Biotech
Via
GlobeNewswire
NKGen Biotech Appoints Paul Y. Song, MD as Chief Executive Officer
January 10, 2023
From
NKGen Biotech
Via
GlobeNewswire
NKGen Biotech Announces Collaboration with the Parkinson’s Foundation to Bring Its Novel Natural Killer Cell Therapy to the Clinic for Advanced Parkinson’s Disease
November 04, 2022
From
NKGen Biotech
Via
GlobeNewswire
NKGen Biotech Receives IND Clearance from FDA for SNK02 Allogeneic Natural Killer Cell Therapy for Solid Tumors
October 17, 2022
From
NKGen Biotech
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.